| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1K | +0.0% | — |
| R&D Expense | $969K | -19.2% | +54.7% |
| SG&A Expense | $667K | -5.5% | +7.4% |
| Operating Income | -$1.7M | +13.2% | -32.7% |
| Net Income | -$1.5M | +3.9% | +56.8% |
| EPS (Basic) | $0.00 | — | — |
| EPS (Diluted) | $0.00 | — | — |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $14.4M | -56.9% | -63.6% |
| Short-term Investments | $19.8M | +902.6% | — |
| Current Assets | $34.3M | -3.5% | -13.8% |
| Total Assets | $34.5M | -3.5% | -13.8% |
| Total Liabilities | $741K | -3.4% | +41.5% |
| Stockholders' Equity | $33.2M | -3.5% |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$2.3M | -93.6% | — |
| Investing Cash Flow | -$16.9M | -1755.1% | — |
| Financing Cash Flow | -$1.0M | +0.0% | — |
| -14.4% |